• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种替代的紫杉醇微乳制剂:超敏反应评估及药代动力学特征

An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.

作者信息

He Lei, Wang Gui-ling, Zhang Qiang

机构信息

Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing 100083, People's Republic of China.

出版信息

Int J Pharm. 2003 Jan 2;250(1):45-50. doi: 10.1016/s0378-5173(02)00478-7.

DOI:10.1016/s0378-5173(02)00478-7
PMID:12480272
Abstract

Based on the clinical fact that paclitaxel injection (Taxol) frequently causes hypersensitivity reactions, we prepared an alternative paclitaxel microemulsion with small particle size (17.2 nm). The hypersensitivity evaluation and pharmacokinetic behavior in rats were conducted to assess the new microemulsion. The results showed that the new microemulsion was negative and the placebo Taxol solution was positive with regard to allergic reactions. In the pharmacokinetic study, five rats were administrated Taxol or paclitaxel microemulsion. Blood samples were collected at 0, 0.25, 0.5, 1, 2, 4, 6, 8, 10, 12, 14 h and paclitaxel determined by HPLC. The area under the curve (AUC) was significantly higher in the microemulsion group (34.98 microg ml(-1) h) than that in the Taxol group (21.98 microg ml(-1) h). Also, the K(10) was much smaller in the microemulsion group (0.57 h(-1)) compared with the Taxol group (1.29 h(-1)), showing the elimination rate was much slower in the former than in the latter. Compared with Taxol, the paclitaxel microemulsion caused less toxicity and had a longer circulation time in rats.

摘要

基于紫杉醇注射液(泰素)常引起过敏反应这一临床事实,我们制备了一种粒径较小(17.2纳米)的替代紫杉醇微乳剂。对大鼠进行了过敏反应评估和药代动力学行为研究,以评价这种新型微乳剂。结果显示,新型微乳剂在过敏反应方面呈阴性,而安慰剂紫杉醇溶液呈阳性。在药代动力学研究中,给5只大鼠分别注射紫杉醇或紫杉醇微乳剂。在0、0.25、0.5、1、2、4、6、8、10、12、14小时采集血样,并用高效液相色谱法测定紫杉醇含量。微乳剂组的曲线下面积(AUC)(34.98微克·毫升-1·小时)显著高于紫杉醇组(21.98微克·毫升-1·小时)。此外,微乳剂组的K(10)(0.57小时-1)比紫杉醇组(1.29小时-1)小得多,表明前者的消除速率比后者慢得多。与紫杉醇相比,紫杉醇微乳剂在大鼠体内的毒性较小,循环时间更长。

相似文献

1
An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.一种替代的紫杉醇微乳制剂:超敏反应评估及药代动力学特征
Int J Pharm. 2003 Jan 2;250(1):45-50. doi: 10.1016/s0378-5173(02)00478-7.
2
An alternative paclitaxel self-emulsifying microemulsion formulation: preparation, pharmacokinetic profile, and hypersensitivity evaluation.一种替代的紫杉醇自乳化微乳制剂:制备、药代动力学特征及超敏反应评估。
PDA J Pharm Sci Technol. 2006 Mar-Apr;60(2):89-94.
3
[Studies on hypersensitivity and pharmacokinetics of paclitaxel microemulsion].[紫杉醇微乳剂的过敏反应及药代动力学研究]
Yao Xue Xue Bao. 2003 Mar;38(3):227-30.
4
In vivo biocompatibility, pharmacokinetics, antitumor efficacy, and hypersensitivity evaluation of ionic liquid-mediated paclitaxel formulations.离子液体介导的紫杉醇制剂的体内生物相容性、药代动力学、抗肿瘤疗效和过敏反应评价。
Int J Pharm. 2019 Jun 30;565:219-226. doi: 10.1016/j.ijpharm.2019.05.020. Epub 2019 May 8.
5
Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.水飞蓟素及其制剂对紫杉醇在大鼠体内口服生物利用度的影响。
Eur J Pharm Sci. 2012 Feb 14;45(3):296-301. doi: 10.1016/j.ejps.2011.11.021. Epub 2011 Dec 8.
6
Cremophor-free intravenous microemulsions for paclitaxel I: formulation, cytotoxicity and hemolysis.紫杉醇无聚氧乙烯蓖麻油静脉注射微乳剂 I:制剂、细胞毒性和溶血作用
Int J Pharm. 2008 Feb 12;349(1-2):108-16. doi: 10.1016/j.ijpharm.2007.07.042. Epub 2007 Aug 7.
7
Cremophor-free intravenous microemulsions for paclitaxel II. Stability, in vitro release and pharmacokinetics.紫杉醇的无聚氧乙烯蓖麻油静脉微乳剂II.稳定性、体外释放及药代动力学
Int J Pharm. 2008 Feb 12;349(1-2):117-23. doi: 10.1016/j.ijpharm.2007.07.043. Epub 2007 Aug 7.
8
Paclitaxel-loaded niosomes for intravenous administration: pharmacokinetics and tissue distribution in rats.载紫杉醇的脂质体静脉给药:在大鼠体内的药代动力学和组织分布。
Turk J Med Sci. 2015;45(6):1403-12.
9
Antitumor efficacy of a novel CLA-PTX microemulsion against brain tumors: in vitro and in vivo findings.新型 CLA-PTX 微乳液抗脑肿瘤的疗效:体外和体内研究结果。
Int J Nanomedicine. 2012;7:6105-14. doi: 10.2147/IJN.S38927. Epub 2012 Dec 17.
10
Formulation, characterization and hypersensitivity evaluation of an intravenous emulsion loaded with a paclitaxel-cholesterol complex.载有紫杉醇-胆固醇复合物的静脉乳剂的处方、表征及过敏反应评估
Chem Pharm Bull (Tokyo). 2011;59(3):321-6. doi: 10.1248/cpb.59.321.

引用本文的文献

1
Research Progress on Taxus Extraction and Formulation Preparation Technologies.紫杉提取及制剂制备技术的研究进展。
Molecules. 2024 May 13;29(10):2291. doi: 10.3390/molecules29102291.
2
A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo.一种具有高载药量的载紫杉醇白蛋白纳米粒的新型制备方法及其体内外评价。
PLoS One. 2021 Apr 28;16(4):e0250670. doi: 10.1371/journal.pone.0250670. eCollection 2021.
3
The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
负载紫杉醇/二甲基-β-环糊精包合物的壳聚糖纳米粒的制备、表征及药代动力学研究
Int J Nanomedicine. 2015 Jul 3;10:4309-19. doi: 10.2147/IJN.S83508. eCollection 2015.
4
Nano polymeric carrier fabrication technologies for advanced antitumor therapy.用于先进抗肿瘤治疗的纳米聚合物载体制造技术。
Biomed Res Int. 2013;2013:305089. doi: 10.1155/2013/305089. Epub 2013 Dec 4.
5
Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges.设计旨在改善患者治疗效果的紫杉醇药物递送系统:现状与挑战。
ISRN Pharmacol. 2012;2012:623139. doi: 10.5402/2012/623139. Epub 2012 Aug 12.
6
Drug targeting to infectious diseases by nanoparticles surface functionalized with special biomolecules.纳米粒子表面通过特殊生物分子功能化实现对传染病的药物靶向。
Curr Med Chem. 2012;19(19):3196-202. doi: 10.2174/092986712800784630.
7
Paclitaxel gelatin nanoparticles for intravesical bladder cancer therapy.紫杉醇明胶纳米粒用于膀胱癌的膀胱内治疗。
J Urol. 2011 Apr;185(4):1478-83. doi: 10.1016/j.juro.2010.11.091. Epub 2011 Feb 19.
8
A novel paclitaxel microemulsion containing a reduced amount of Cremophor EL: pharmacokinetics, biodistribution, and in vivo antitumor efficacy and safety.一种含较少聚氧乙烯蓖麻油(Cremophor EL)的新型紫杉醇微乳剂:药代动力学、生物分布及体内抗肿瘤疗效与安全性
J Biomed Biotechnol. 2011;2011:854872. doi: 10.1155/2011/854872. Epub 2011 Jan 20.
9
Evaluation of docetaxel-loaded intravenous lipid emulsion: pharmacokinetics, tissue distribution, antitumor activity, safety and toxicity.多西紫杉醇静脉用脂肪乳剂的评价:药代动力学、组织分布、抗肿瘤活性、安全性和毒性。
Pharm Res. 2010 Aug;27(8):1687-702. doi: 10.1007/s11095-010-0180-0. Epub 2010 Jun 15.
10
Polymeric micelles for delivery of poorly soluble drugs: preparation and anticancer activity in vitro of paclitaxel incorporated into mixed micelles based on poly(ethylene glycol)-lipid conjugate and positively charged lipids.用于递送难溶性药物的聚合物胶束:基于聚乙二醇 - 脂质共轭物和带正电荷脂质的混合胶束中紫杉醇的制备及体外抗癌活性
J Drug Target. 2005 Jan;13(1):73-80. doi: 10.1080/10611860400011935.